Liporyz® LT Labo
Liporyz® LT Labo
Liporyz® LT Labo
Liporyz® LT Labo
Liporyz® LT Labo
Liporyz® LT Labo

Liporyz®

180 capsules - 1 month treatment | 270 capsules - 2 months treatment

Liporyz®, a natural and patented solution based on rice bran oil to effectively support lipid balance and maintain normal cholesterol levels. Statin-free, side-effect-free, and rich in phytosterols, vitamin E, chromium, and zinc.

🩸Santé cardiovasculaire
Liporyz®
  • Description
  • Directions for use
  • Composition

Présentation détaillée

Liporyz® is a patented formula based on rice bran oil, a natural alternative for maintaining balanced cholesterol levels without resorting to statins.

Unlike red yeast rice (RYR), Liporyz® works gently, without disrupting cholesterol synthesis in the liver and without the side effects associated with statins, such as muscle pain or fatigue. The rice bran oil used in Liporyz® is extracted from the husk of the rice grain by first cold pressing. It is rich in gamma-oryzanol and phytosterols, which help reduce the intestinal absorption of dietary cholesterol, while protecting cells thanks to its natural antioxidant content.

With more than 15 years of expertise and 23 million days of use, Liporyz® is an essential reference for promoting optimal cardiovascular health.

Image de présentation détaillée

Bienfaits

Contributes to the maintenance of normal cholesterol levels: Phytosterols and gamma-oryzanol in rice bran oil help reduce the absorption of cholesterol in the intestine*. Lowering blood cholesterol may help reduce the risk of cardiovascular disease.

✅ Gentle and well-tolerated alternative: Unlike red yeast rice, which contains monacolin K (a compound similar to synthetic statins), rice bran oil acts gently and does not cause muscle pain, fatigue, or liver problems. In addition, it does not pose a risk of contamination by mycotoxins such as citrinin, which are sometimes found in red yeast rice products.

✅ Antioxidant action: Rice bran oil is naturally rich in vitamin E, which helps protect cells against oxidative stress, a phenomenon that can damage cell membranes and accelerate their aging.

✅ Metabolic balance: Chromium contributes to the maintenance of normal blood glucose levels and the normal metabolism of macronutrients such as carbohydrates and lipids. Zinc supports the enzymatic functions involved in normal fatty acid metabolism, essential for lipid balance.

The beneficial effects of vitamin E, chromium, and zinc mentioned above are achieved with a daily intake covering at least 15% of the Nutrient Reference Values (NRVs). This product provides up to 100% of the NRVs, thus guaranteeing their effectiveness.

*The beneficial effect of phytosterols on reducing blood cholesterol is achieved with a daily intake of at least 0.8 g of phytosterols. Thanks to rice bran oil and added phytosterols, this product provides 1.93 g of phytosterols per day, thus effectively contributing to the maintenance of normal cholesterol levels.

À qui s'adresse ce produit ?

This product is intended for anyone who:

  • Wants to regulate blood cholesterol naturally and without statins.

  • Has excess LDL cholesterol (bad cholesterol) confirmed by a blood test.

  • Wishes to contribute to maintaining good cardiovascular health through a natural approach.

  • Cannot tolerate statins or wants an alternative without musculoskeletal side effects.

  • Want to avoid the side effects associated with red yeast rice.

This product is not a medicine and cannot legally claim to prevent, treat or cure any disease..

Icône Compléo Décrypté par Compléo

Stop the preconceived ideas about cholesterol!

Cholesterol is often perceived as an enemy to be defeated, but this view is simplistic and misleading. In reality, it plays a vital role in the body. This lipid is essential for the production of cell membranes, hormones (such as estrogen and testosterone), and vitamin D.

However, it is the balance between the different forms of cholesterol that matters. We distinguish:

  • "Bad" cholesterol (LDL)High LDL levels lead to cholesterol buildup in the arteries and increased cardiovascular risk.
  • "Good" cholesterol (HDL): Which helps transport excess cholesterol to the liver to be eliminated with the bile.

Having high cholesterol isn't always a problem. It all depends on the ratios of LDL and HDL, as well as other factors such as age, family history, cardiovascular risk, and lifestyle.

Liporyz® - Illustration haute Décrypté par Compléo

Myth: All cholesterol comes from food

False. Approximately 75% of our cholesterol is produced by the liver, while only 25% comes from what we eat. This explains why some people have high cholesterol even when eating a balanced diet: genetic or metabolic factors are often the cause.

Myth: Reducing fat is enough to regulate cholesterol

It's more complex. While saturated and trans fats contribute to increased LDL, a diet rich in fiber, healthy fatty acids (omega-3, -6, and -9), and plant sterols plays a key role in rebalancing the LDL/HDL ratio.

In short, cholesterol is not something to be demonized but rather understood.

Conseils d'utilisation

Recommended dosage

  • 3 capsules per day (1 morning, 1 midday, 1 evening).

  • Preferably during meals, for better absorption.

  • With a large glass of water.

Recommended duration

  • Can be taken year-round for ongoing support. For extended use, it is always advisable to seek the advice of a healthcare professional.

  • Improvement can be seen after 4 to 6 weeks of regular use.

Précautions d'emploi

  • To be consumed as part of a healthy lifestyle and a varied and balanced diet, rich in fruits and vegetables.

  • Keep out of reach of young children.

  • Do not exceed the recommended daily dose.

  • Reserved for adults.

  • Not intended for people who do not need to control their cholesterol.

  • If you are on cholesterol-lowering medication, use this product under medical supervision.

Contre-indications

  • Déconseillé aux femmes enceintes ou allaitantes sans avis médical
  • Par mesure de précaution, ne convient pas aux femmes allaitantes
  • Ne pas utiliser en cas d'hypersensibilité à l'un des ingrédients
Liporyz®

Composition

Bioactives

  • Rice Bran Oil (Oryza sativa L.) :Extracted by first cold pressing, this oil is a valuable source of phytosterols and gamma-oryzanol, known for their role in reducing intestinal cholesterol absorption. Its active compounds, such as tocotrienols and tocopherols (natural forms of vitamin E), also help protect cells from oxidative stress.

  • Phytosterols (soy derivatives):Derived from plants, these structured lipid compounds, like cholesterol, work by inhibiting its absorption in the intestine. They thus help maintain normal cholesterol levels. The beneficial effect of phytosterols on reducing blood cholesterol is achieved with a daily consumption of at least 0.8 g of phytosterols. Thanks to rice bran oil and added phytosterols, this product provides 1.93 g of phytosterols per day, thus effectively contributing to the maintenance of normal cholesterol levels.

Vitamins

  • Natural Vitamin E:Present in the form of D-alpha-tocopherols, it protects the body's lipids against oxidation, thus contributing to the preservation of cell membranes.

Minerals

  • Zinc:This trace element supports normal fatty acid metabolism, essential for lipid balance and the proper functioning of many metabolic enzymes.

  • Chrome:Known for its role in carbohydrate and lipid metabolism, it helps maintain normal blood sugar levels and participates in the regulation of cholesterol.

Other components

  • Sunflower lecithin:A natural emulsifier that helps maintain formulation stability and improves the bioavailability of fat-soluble phytosterols.

  • Beeswax:Used as a natural thickener, it guarantees the consistency and stability of the capsules and protects the active ingredients.

  • Capsule tunic:

- Gelatin:Encloses the formulation for easy intake and optimal preservation.

- Glycerol:Keeps the capsule flexible and prevents it from drying out.

- Regular caramel:Adds a natural tint to the tunic without interfering with the product's properties.

Valeurs nutritionnelles

Tableau des valeurs nutritionnelles
SYNERGIES

To be associated with

Références scientifiques

1- Pownall, HJ, & Gotto, AM (2019). Cholesterol: Can't live with it, Can't live without it. Methodist DeBakey Cardiovascular Journal, 15(1), 9–15. https://doi.org/10.14797/mdcj-15-1-9.2- Borén, J., Chapman, MJ, Krauss, RM, Packard, CJ, Bentzon, JF, Binder, CJ, et al. (2020). Low-density lipoproteins cause atherosclerotic cardiovascular disease: Pathophysiological, genetic, and therapeutic insights: A consensus statement from the European atherosclerosis society consensus panel. European Heart Journal, 41(24), 2313–2330. https://doi.org/10.1093/eurheartj/ehz962.

3- Bogh, MKB, Schmedes, AV, Philipsen, PA, Thieden, E., & Wulf, HC (2010). Vitamin D production after UVB exposure depends on baseline vitamin D and Total cholesterol but not on skin pigmentation. Journal of Investigative Dermatology, 130(2), 546–553. https://doi.org/10.1038/jid.2009.323.

4- Brown, MS, & Goldstein, JL (1986). A receptor-mediated pathway for cholesterol homeostasis. Science, 232(4746), 34. https://doi.org/10.1126/science.3513311.

5- Mortensen, MB, & Nordestgaard, BG (2020). Elevated LDL cholesterol and increased risk of myocardial infarction and atherosclerotic cardiovascular disease in individuals aged 70-100 years: a contemporary primary prevention cohort. The Lancet, 396(10263), 1644–1652. https://doi.org/10.1016/S0140-6736(20)32233-9.

6- Ference, BA, Ginsberg, HN, Graham, I., Ray, KK, Packard, CJ, Bruckert, E., et al. (2017). Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetics, epidemiologic, and clinical studies. A consensus statement from the European atherosclerosis society consensus panel. European Heart Journal, 38(32), 2459–2472. https://doi.org/10.1093/eurheartj/ehx144.

7- Mooney, KM, & McAuley, MT (2015). Cardiovascular disease and healthy aging. Journal of Integrative Cardiology, 1(4), 76–78. https://doi.org/10.15761/JIC.1000122.

8- Pappa, E., Elisaf, MS, Kostara, C., Bairaktari, E., & Tsimihodimos, VK (2020). Cardioprotective properties of HDL: Structural and functional considerations. Current Medicinal Chemistry, 27(18), 2964–2978.

9-Afonso, MS, Machado, RM, Lavrador, MS, Quintao, ECR, Moore, KJ, & Lottenberg, AM (2018). Molecular pathways underlying cholesterol homeostasis. Nutrients, 10(6), 760.

10- Alphonse, PAS, Ramprasath, V., & Jones, PJH (2017). Effect of dietary cholesterol and plant sterol consumption on plasma lipid responsiveness and cholesterol trafficking in healthy individuals. British Journal of Nutrition, 117(1), 56–66. https://doi.org/10.1017/S0007114516004530.

11- Herron, KL, Vega-Lopez, S., Conde, K., Ramjiganesh, T., Shachter, NS, & Fernandez, ML (2003). Men classified as hypo- or hyperresponders to dietary cholesterol feeding exhibit differences in lipoprotein metabolism. The Journal of Nutrition, 133(4), 1036–1042. https://doi.org/10.1093/jn/133.4.1036.

12- Bosner, MS, Lange, LG, Stenson, WF, & Ostlund, RE, Jr. (1999). Percent cholesterol absorption in normal women and men quantified with dual stable isotopic tracers and negative ion mass spectrometry. Journal of Lipid Research, 40(2), 302–308.

13- Ference, BA, Majeed, F., Penumetcha, R., Flack, JM, & Brook, RD (2015). Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2 × 2 factorial Mendelian randomization study. Journal of the American College of Cardiology, 65(15), 1552–1561. https://doi.org/10.1016/j.jacc.2015.02.020.

14- Yue, Y.-H., Liu, L.-Y., Hu, L., Li, Y.-M., Mao, J.-P., Yang, X.-Y., et al. (2017). The association of lipid metabolism relative gene polymorphisms and ischemic stroke in Han and Uighur population of Xinjiang. Lipids in Health and Disease, 16(1), 120. https://doi.org/10.1186/s12944-017-0491-9.

15- McAuley, MT (2018). The interplay between cholesterol metabolism and intrinsic aging. Sub-Cellular Biochemistry, 90, 99–118. https://doi.org/10.1007/978-981-13-2835-0_4.

16- Morgan, AE, & McAuley, MT (2020). Cholesterol homeostasis: An in silico investigation into how aging disrupts its key hepatic regulatory mechanisms. Biology (Basel), 9(10). https://doi.org/10.3390/biology9100314.

17- Abbott, RD, Garrison, RJ, Wilson, P., Epstein, FH, Castelli, WP, Feinleib, M., et al. (1983). Joint distribution of lipoprotein cholesterol classes. The Framingham study. Arteriosclerosis: An Official Journal of the American Heart Association, Inc, 3(3), 260–272.

18-Carroll, MD, Lacher, DA, Sorlie, PD, Cleeman, JI, Gordon, DJ, Wolz, M., et al. (2005). Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA, 294(14), 1773–1781.

19- Feng, L., Nian, S., Tong, Z., Zhu, Y., Li, Y., Zhang, C., et al. (2020). Age-related trends in lipid levels: A large-scale cross-sectional study of the general Chinese population. BMJ Open, 10(3). https://doi.org/10.1136/bmjopen-2019-034226.

20- Morgan, A., Mooney, K., & McAuley, M. (2016). Obesity and the dysregulation of fatty acid metabolism: Implications for healthy aging. Expert Review of Endocrinology and Metabolism, 11(6), 501–510. https://doi.org/10.1080/174466 51.2016.1245141.

21- Moreau, RA, Whitaker, BD, & Hicks, KB (2002). Phytosterols, phytostanols, and their conjugates in foods: structural diversity, quantitative analysis, and health-promoting uses. Progress in lipid research, 41(6), 457-500.

22- PIIRONEN, Vieno, LINDSAY, David G., MIETTINEN, Tatu A., et al. Plant sterols: biosynthesis, biological function and their importance to human nutrition. Journal of the Science of Food and Agriculture, 2000, vol. 80, no. 7, p. 939-966.

23- Calpe-Berdiel, L., Escolà-Gil, JC, & Blanco-Vaca, F. (2009). New insights into the molecular actions of plant sterols and stanols in cholesterol metabolism. Atherosclerosis, 203(1), 18–31.

24-Fidalgo Rodríguez, JL, Dynarowicz-Latka, P., & Miñones Conde, J. (2020). How unsaturated fatty acids and plant stanols affect sterols plasma level and cellular membranes? Review on model studies involving the Langmuir monolayer technique. Chemistry and Physics of Lipids, 232, 104968.

25- Hovenkamp, E., Demonty, I., Plat, J., Lütjohann, D., Mensink, RP, & Trautwein, EA (2008). Biological effects of oxidized phytosterols: A review of the current knowledge. Progress in Lipid Research, 47(1), 37–49.

26- de Jong, A., Plat, J., & Mensink, RP (2003). Metabolic effects of plant sterols and stanols (review). The Journal of Nutritional Biochemistry, 14(7), 362–369.

27 - Demonty, I., Ras, RT, van der Knaap, HC, Duchateau, GS, Meijer, L., Zock, PL, et al. (2009). Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake. The Journal of Nutrition, 139(2), 271–284.

28- Musa-Veloso, K., Poon, TH, Elliot, JA, & Chung, C. (2011). A comparison of the LDL-cholesterol lowering efficacy of plant stanols and plant sterols over a continuous dose range: Results of a meta-analysis of randomized.

29- Hu W, Wells JH, Shin TS, Godber JS. Comparison of isopropanol and hexane for extraction of vitamin E and oryzanols from stabilized rice bran. JAOCS 1996;73:1653–6.

30-Orthoefer FT, Eastman J. Rice Bran and Oil. In: Champagne ET, editor. Rice Chemistry and Technology 3rd ed. St Paul MN: Ameri-can Association of Cereal Chemists; 2004. p. 569–93.

31- Saunders RM. Rice bran: Composition and potential food uses. Food Rev Int 1985;3:465–95.

32- Saunders RM. The properties of rice bran as a food stuff. Cereal Foods World 1990;35(632):634–6.

33- Luh DS. Rice: Production and utilization. Westport, CT: AVI Publishing; 1980.

34- Marshall WE, Wadsworth JI. Rice science and technology. New York, NY: Marcel Dekker; 1994.

35- Ju YH, Vali SR. Rice bran oil as a potential resource for biodiesel: A review. J Sci Ind Res 2005;64:866–82.

36- Nantiyakul N, Furse S, Fisk ID, Tucker G, Gray DA. Isolation and characterization of oil bodies from Oryza sativa bran and studies of their physical properties. J Cereal Sci 2013;57:141–5.

37-Most MM, Tully R, Morales S, Lefevre M. Rice bran oil, not fiber, lower cholesterol in humans. Am J Clin Nutr 2005;81:64–8.

38-Rong N, Ausman LM, Nicolosi RJ. Oryzanol decreases cholesterol absorption and aortic fatty streaks in hamsters. Lipids 1997;32:303–9.

39- Sugano M, Koba K, Tsuji E. Health benefits of rice bran oil. Anticancer Res 1999;19:3651–7.

40- Wester I. Cholesterol-lowering effect of plant sterols. Eur J Lipid Sci Technol 2000;102:37–44.

41- Xu Z, Hua N, Godber JS. Antioxidant activity of tocopher-ols, tocotrienols, and γ-oryzanol components from rice bran against cholesterol oxidation accelerated by 2,2′-azobis (2-methylpropionamidine) dihydrochloride. J Agric Food Chem 2001;49:2077–81.

42- Nicolosi RJ, Ausman LM, Hegsted DM. Rice bran oil lowers serum total and low density lipoprotein cholesterol and Apo B levels in nonhuman primates. Artherosclerosis 1991;88:133–42.

43- Suzuki S, Oshima S. Influence of blending of edible fats and oils on human serum cholesterol level (Part 1). Jpn J Nutr 1970;28:3–6.

44- Raghuram TC, Rao UB, Rukmini C. Studies on hypolipidemic effects of dietary rice bran oil in human subjects. Nutr Rep Int 1989;39:889–95.

45- Jolfaie NR, Rouhani MH, Surkan PJ, Siassi F, Azadbakht L. Rice Bran Oil Decreases Total and LDL Cholesterol in Humans: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials. Horm Metab Res. 2016 Jul;48(7):417-26. doi:10.1055/s-0042-105748. Epub 2016 Jun 16. PMID: 27311126.

46- Pourrajab B, Sohouli MH, Amirinejad A, Fatahi S, Găman MA, Shidfar F. The impact of rice bran oil consumption on the serum lipid profile in adults: a systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2022;62(22):6005-6015. doi:10.1080/10408398.2021.1895062. Epub 2021 Mar 10. PMID: 33715544.

47- King JC, Cousins RJ. Zinc. In: Shils ME, Shike M, Ross AC, Caballero B, Cousins RJ, editors. Modern Nutrition in Health and Disease. Philadelphia: Lippincott Williams and Wilkins; 2006. p. 271–85.

48- Coleman JE. Zinc proteins: enzymes, storage proteins, transcription factors, and replication proteins. Annu Rev Biochem. 1992;61:897–946.

49- Vallee BL, Falchuk KH. The biochemical basis of zinc physiology. Physiol Rev. 1993;73(1):79–118.

50- Ranasinghe, P., Wathurapatha, W., Ishara, M. et al. Effects of Zinc supplementation on serum lipids: a systematic review and meta-analysis. Nutr Metab (Lond) 12, 26 (2015). https://doi.org/10.1186/s12986-015-0023-4

51- Rychter, A.M., Hryhorowicz, S., Słomski, R., Dobrowolska, A., & Krela-Kaźmierczak, I. (2022). Antioxidant effects of vitamin E and risk of cardiovascular disease in women with obesity–a narrative review. Clinical Nutrition.

52- Zavoshy R, Noroozi M, Jahanihashemi H. Effect of low calorie diet with rice bran oil on cardiovascular risk factors in hyperlipidemic patients. J Res Med Sci 2012; 17:626–631

53- Cicero, A.F., Fogacci, F., & Banach, M. (2019). Red yeast rice for hypercholesterolemia. Methodist DeBakey cardiovascular journal, 15(3), 192.

54- https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2018.5368

55- Cabral CE, Klein MRST. Phytosterols in the Treatment of Hypercholesterolemia and Prevention of Cardiovascular Diseases. Arq Arm Cardiol. 2017 Nov;109(5):475-482. doi: 10.5935/abc.20170158. PMID: 29267628; PMCID: PMC5729784.

56- Liao, CD, Chen, YC, Lin, HY, Chiueh, LC, & Shih, DYC (2014). Incidence of citrinin in red yeast rice and various commercial Monascus products in Taiwan from 2009 to 2012. Food Control, 38, 178-183.

57- Yang, R., Zhang, L., Li, P., Yu, L., Mao, J., Wang, X., & Zhang, Q. (2018). A review of chemical composition and nutritional properties of minor vegetable oils in China. Trends in food science & technology, 74, 26-32.